|
|
Salk Institute Commemorates Jonas Salk
| |
With the centenary of Jonas Salk's birth drawing near, members of the Salk Institute's senior faculty have been reminiscing about the visionary scientist whose vaccine turned the tide on polio in 1955 and whose research facility continues to change medical history today.
Born on October 28, 1914, Salk would inspire and challenge his Institute colleagues as much in their scientific pursuits as in their worldviews. A series of videos capturing the remembrances of those privileged to know the man include professors Walter Eckhart, Ron Evans, Tony Hunter, Greg Lemke and Inder Verma, as well as Salk's eldest son, Peter Salk.
To view these legacy videos on the Jonas Salk 100 webpage, click here � |
|
|
|
| |
|
|
 | Peter Salk
|
|
|
Vitamin D derivative helps fight pancreatic cancer
|
 |
From Left: Ron Evans, Mira Sherman,
Ruth Yu, Ann Atkins, Tiffany Tseng and Michael Downes
|
|
|
Pancreatic cancer is one of the deadliest forms of cancer, a fact highlighted in recent years by the deaths of well-known figures such as Steve Jobs and
Patrick Swayze.
In recent work published in Cell, Ronald Evans and colleagues found that a synthetic derivative of vitamin D collapses the barrier of cells shielding pancreatic tumors, making this seemingly impenetrable cancer much more susceptible to therapeutic drugs. This exciting research has already advanced to human trials.
|
|
Cheers for two prestigious NIH wins at the Salk!
|
 | |
Margarita Behrens and Joseph Ecker
|
|
|
|
 | |
Hu Cang
|
|
Additionally, Salk scientists have scored a rare hat trick with a third assistant professor being named a recipient of the prestigious NIH Director's New Innovator Award. Congratulations to Hu Cang, who was awarded $1.5 million this year!
Read more �
|
|
|
This series of six concerts features stunning performances by some of the hottest established and emerging classical and jazz musicians, as well as riveting talks about the latest scientific discoveries by the Institute's world-renowned scientists.
|
|
Computational Neurobiology Laboratory
November 2, 2014
|
Laboratory of Genetics
February 22, 2015
| |
Vision Center Laboratory
December 7, 2014
|
Gene Expression Laboratory
April 26, 2015
| |
Molecular and Cell Biology Laboratory
January 25, 2015
|
Regulatory Biology Laboratory
June 7, 2015
|
|
 | |
From left: Shili Chen, Alan Saghatelian and Tejia Zhang
|
|
Professor Alan Saghatelian's lab, along with collaborators at
Beth Israel Deaconess Medical Center, have discovered a new class of molecules (produced in human and mouse fat) that protects against diabetes.
View video �
Press release: Scientists discover a 'good' fat that
fights diabetes
Select media coverage: Daily Express, Daily Mail, Global Post
|
 | | Vicki Lundblad and Timothy Tucey |
|
Professor Vicki Lundblad's lab has discovered an on-and-off "switch" in cells that may hold the key to healthy aging. This switch points to a way to encourage healthy cells to keep dividing and generating, for example, new lung or liver tissue, even in old age.
Press release: Scientists discover an on/off switch for
aging cells
Select media coverage: R & D Magazine, GEN
|
 | | Tom Albright |
|
A National Academy of Sciences committee, of which Tom Albright, Director of Salk's Vision Center Laboratory, acts as co-chair, released the first comprehensive report on the unreliability of eye witness accounts.
Select media coverage: Time, Atlantic, USA Today
|
|
Your support makes it possible for Salk to recruit and retain top-tier
scientists, acquire the latest cutting-edge technology, and fuel innovative research initiatives, all of which provide extraordinary opportunities for
scientific discovery.
| |
|
|
|
Upcoming Events
|
| |
San Diego Salkexcellerators
October 22, 2014
Private reception and scientific presentation with Alan Saghatelian
|
President's Club Luncheon
December 4, 2014
For Information contact:
Megan Shockro at [email protected]
| |
Salk Science & Music Series
November 2, 2014
|
Salk Science & Music Series
December 7, 2014
|
|
|
Science image for download
|
|
In the pancreatic tumor microenvironment, non-cancerous stromal cells (blue) impede the delivery and efficacy of chemotherapy.
Image courtesy: The Evans lab: Ron Evans, Mira Sherman, Ruth Yu, Ann Atkins, Tiffany Tseng and Michael Downes
Click here �
|
|
| Looking for previous issues of Salk Central?
|  |
|
|
|
|
 |
|
|
|
